WKWiktoria Knobelsdorf

Wiktoria Knobelsdorf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wiktoria Knobelsdorf has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    OBESITY AND EXECUTIVE FUNCTIONS: THE CRITICAL ROLE OF THE PREFRONTAL CORTEX – A LITERATURE REVIEW

    by Maria Łagódka, Gabriela Furtak, Dominika Pietrzyk, Katarzyna Zając, Wiktoria Knobelsdorf, Wiktor Daniszewski, Maciej Ćmil, Bartosz Oder, Wojciech Karchut, Michał Pogoda

    Introduction: Obesity is a chronic metabolic disease characterized by excessive fat accumulation and a multifactorial etiology. One potential contributing factor is impaired executive functioning in individuals with obesity, including deficits in planning, decision-making, and inhibitory control. These impairments may lead to increased impulsivity and difficulties with self-regulation in the context of eating behavior, ultimately contributing to excessive body weight and challenges in achieving weight reduction. The primary brain region responsible for executive functions is the prefrontal cortex. Aim of the study: This review aims to synthesize recent research on the relationship between obesity and executive functions, with particular focus on the prefrontal cortex as both a key modulator of these cognitive processes and a potential target for therapeutic interventions in the management of excessive body weight. Methods: This review was compiled through an extensive analysis of the PubMed and Google Scholar databases. It includes a literature review from [insert year range], with particular emphasis on articles from the past 5 years focusing on the keywords: „obesity”, „prefrontal cortex”, „executive function”, „cognitive function”. Conclusions: Obesity represents a growing health problem with significant clinical and social consequences. Alterations in the prefrontal cortex observed in individuals with obesity may lead to impairments in executive functions, such as reduced impulse control and decision-making difficulties. These dysfunctions can contribute to the development of obesity, while obesity itself may further exacerbate them, creating a vicious cycle. Therefore, interventions aimed at enhancing executive functions could serve as a valuable complement to obesity treatment. However, further consistent research is needed to determine their effectiveness and practical applicability.

  • DERMATOMYOSITIS AND STATIN-ASSOCIATED MYOPATHIES: A PRACTICAL APPROACH TO DIFFERENTIAL DIAGNOSIS: A NARRATIVE REVIEW

    by Wiktor Daniszewski, Jakub Rodziewicz, Wiktoria Knobelsdorf, Angelika Jankowska, Anna Wawrzeczko, Magdalena Gostół

    Background Statins are widely used to reduce cardiovascular morbidity and mortality, but muscle symptoms during statin therapy are a frequent clinical problem. Most cases represent reversible toxic statin myopathy, whereas statin-associated immune-mediated necrotizing myopathy and dermatomyositis require different diagnostic and therapeutic strategies. Aims This narrative review summarizes the clinical spectrum of statin-associated muscle disorders and dermatomyositis and provides a practical framework for their differential diagnosis. Methods A narrative literature review was performed using PubMed/MEDLINE and Google Scholar. Publications from January 2010 to November 2025 were searched using terms related to statin-associated muscle symptoms, statin myopathy, rhabdomyolysis, immune-mediated necrotizing myopathy, anti-HMGCR antibodies, dermatomyositis, and inflammatory myopathies. Original studies, clinical reviews, consensus statements, guidelines, and selected clinically relevant case reports were included. No formal systematic review protocol was used. Results Toxic statin myopathy, statin-associated immune-mediated necrotizing myopathy, and dermatomyositis may present with proximal muscle weakness and elevated creatine kinase. Toxic statin myopathy usually improves after statin withdrawal. Immune-mediated necrotizing myopathy is characterized by persistent or progressive weakness despite statin discontinuation and is associated with anti-HMGCR antibodies. Dermatomyositis is distinguished by characteristic skin manifestations, systemic involvement, and increased malignancy risk. Differential diagnosis requires clinical assessment, creatine kinase measurement, autoantibody testing, muscle imaging, and, when needed, muscle biopsy. Conclusions Muscle symptoms during statin therapy should not automatically be attributed to toxic statin myopathy. Persistent weakness, sustained creatine kinase elevation, positive anti-HMGCR antibodies, myositis-specific antibodies, cutaneous signs, or systemic manifestations should prompt evaluation for autoimmune myopathy. Correct differentiation is essential because toxic statin myopathy usually requires lipid-lowering therapy modification, whereas immune-mediated necrotizing myopathy and dermatomyositis require immunosuppressive treatment and specialist follow-up.

  • Open Access

    HEART RATE VARIABILITY (HRV) AS A TOOL FOR OPTIMIZING TRAINING LOAD QUALITY AND RECOVERY IN COMBAT SPORTS: A NARRATIVE REVIEW

    by Jakub Rodziewicz, Wiktor Daniszewski, Viktoria Kretschmer, Magdalena Baranowska, Ewa Sobolewska, Daniel Markowski, Patryk Kondracki, Wiktoria Knobelsdorf

    Background: Elite combat sports such as wrestling, judo, and Brazilian jiu-jitsu impose high physiological demands, necessitating precise training load management and recovery to prevent non-functional overreaching and overtraining syndrome. Heart rate variability has gained prominence as a non-invasive biomarker of autonomic nervous system balance and internal training load. Aim: This narrative review synthesizes evidence on HRV's application for monitoring stress, recovery, and optimizing training in combat sports athletes. Material and methods: A narrative synthesis of 23 peer-reviewed articles was conducted, drawing from databases including PubMed/MEDLINE, Web of Science, and Scopus. Focus areas included HRV physiological mechanisms, associations with performance, and combat sport-specific findings, prioritizing parameters such as RMSSD, HF power, and LF/HF ratio. Results: Time-domain and frequency-domain HRV metrics robustly indicate parasympathetic reactivation and systemic recovery. High-intensity interval training provokes greater acute parasympathetic suppression (e.g., RMSSD -32% vs. -14%) and sympathetic dominance (LF/HF +56% vs. +22%) than volume-oriented training, yet yields superior competitive outcomes in wrestlers (mean score 17.92 vs. 15.08). HRV thresholds differentiate functional adaptation (RMSSD ≈ 82.76 ms) from non-functional overreaching (≈45.97 ms) Conclusions: Routine HRV monitoring facilitates individualized periodization, bioadaptive load adjustments, and overtraining prevention, enhancing performance sustainability in combat sports.

  • Open Access

    BODY COMPOSITION ASSESSMENT AS A TOOL FOR MONITORING DISEASE ACTIVITY AND TREATMENT EFFECTS IN INFLAMMATORY RHEUMATIC DISEASES: A NARRATIVE REVIEW

    by Wiktor Daniszewski, Jakub Rodziewicz, Viktoria Kretschmer, Magdalena Baranowska, Ewa Sobolewska, Markowski Daniel, Zuzanna Dynowska, Dominik Poszwa, Patryk Kondracki, Wiktoria Knobelsdorf

    Background: Inflammatory rheumatic diseases are systemic conditions associated not only with joint inflammation but also with significant alterations in body composition, including loss of lean mass, increased fat mass, and the development of rheumatoid cachexia or sarcopenic obesity. These changes are often independent of body weight or body mass index (BMI) and contribute to functional impairment, increased cardiometabolic risk, and worse clinical outcomes. Despite their clinical relevance, body composition abnormalities remain underrecognized in routine rheumatology practice. Aim: The aim of this narrative review was to summarize current evidence on the pathophysiology, assessment methods, diagnostic criteria, prevalence, clinical significance, and therapeutic implications of body composition abnormalities in inflammatory rheumatic diseases. Material and methods: A narrative review of the literature published between 2004 and 2025 was conducted. Relevant studies, systematic reviews, and clinical guidelines addressing body composition in rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, systemic lupus erythematosus, and other connective tissue diseases were analyzed. Particular attention was given to assessment methods (anthropometry, BIA, DXA, CT, MRI), diagnostic criteria for sarcopenia and cachexia, and the relationship between body composition, disease activity, and treatment. This review was conducted as a narrative synthesis without formal systematic review methodology or quality assessment. Results: Chronic systemic inflammation, physical inactivity, pain, and pharmacotherapy (especially long-term glucocorticoid use) contribute to muscle catabolism, fat redistribution, and the development of unfavorable body composition phenotypes. Sarcopenia prevalence ranges from approximately 15–40% in rheumatoid arthritis and 10–20% in systemic lupus erythematosus. Reduced lean mass and increased visceral adiposity are associated with higher disease activity, greater disability, poorer quality of life, and increased mortality. Advanced assessment techniques such as DXA and imaging modalities allow early detection and monitoring, while effective inflammation control with targeted therapies may partially improve lean mass. Conclusions: Body composition abnormalities are common and clinically significant systemic manifestations of IRDs. Routine assessment using appropriate screening and confirmatory methods may improve risk stratification, support personalized management, and help prevent functional decline and metabolic complications. Integration of body composition evaluation into standard disease monitoring may contribute to more comprehensive and patient-centered care.

  • Open Access

    THE IMPACT OF EXERCISE ON QUALITY OF LIFE IN DIALYSIS PATIENTS

    by Gabriela Furtak, Dominika Pietrzyk, Maria Łagódka, Wiktoria Knobelsdorf, Wiktor Daniszewski, Maciej Ćmil, Katarzyna Zając, Wojciech Karchut, Bartosz Oder, Michał Pogoda

    Background. The global prevalence of kidney failure is increasing, impacting millions. Dialysis patients face unique challenges, leading to a significant decline in their quality of life. Common issues such as sleep disturbances, anxiety, depression, and chronic fatigue are prevalent in this population. While exercise is known to improve physical function of this group of patients, this review specifically explores the impact of sport and physical activity on the quality of life of dialysis patients. Aim. The aim of this review was to show the existing associations between exercise and quality of life in dialysed patients. Material and methods. To gather all currently recognized information on the topic, we performed a search of the literature, including studies up to June 2025. We used PubMed, Cochrane Library, Web of Science and Embase databases. We assessed the information included in articles published in English and Polish. We used a combination of keywords related to exercise, quality of life, dialysis, chronic kidney disease, sleep, depression, anxiety and chronic fatigue. We searched for relevant articles and chose the applicable ones to accomplish the objective of our review. Results. Exercise demonstrably benefits the maintenance and enhancement of quality of life in dialysis patients. By alleviating symptoms of depression and anxiety, sleep disorders, chronic fatigue, and Restless Legs Syndrome (RLS), physical activity positively impacts patients' overall well-being. Conclusions. Our study definitively shows exercise training effectively alleviates a range of debilitating symptoms in hemodialysis patients. This underscores the critical need to integrate tailored exercise interventions to significantly improve the overall health-related quality of life for this vulnerable population.

  • Open Access

    THE IMPACT OF ARTIFICIAL SWEETENERS ON INSULIN RESISTANCE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS): A LITERATURE REVIEW

    by Michał Pogoda, Dominika Pietrzyk, Gabriela Furtak, Maria Łagódka, Katarzyna Zając, Bartosz Oder, Wiktor Daniszewski, Wiktoria Knobelsdorf, Wojciech Karchut, Bartłomiej Gałuszka

    Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting up to 20% of women of reproductive age worldwide. A central feature of PCOS is insulin resistance (IR), which contributes to hyperandrogenism and worsens reproductive and metabolic symptoms. Given the growing prevalence of PCOS and the widespread use of artificial sweeteners (AS) as sugar substitutes, their potential influence on metabolic health in this population warrants closer examination. Aim: This review aims to assess the current literature on the effects of artificial sweeteners on insulin resistance in women with PCOS, to determine whether their use may exacerbate or mitigate metabolic dysfunctions associated with the syndrome. Methods: A narrative literature review was conducted using the most recent and relevant publications. The review focuses on the biochemical and physiological mechanisms of AS, including their effect on cephalic phase insulin secretion, pancreatic beta-cell response, gut microbiota composition, and hormonal signalling related to glucose metabolism and insulin sensitivity. Results: The impact of AS on metabolic health appears to be heterogeneous and dose-dependent. Some sweeteners, such as saccharin and sucralose, may influence insulin secretion and gut microbiota in ways that contribute to glucose intolerance and IR. However, evidence is inconsistent and varies by sweetener type and study model. In PCOS patients, where IR is a core pathological feature, the use of certain artificial sweeteners may potentially worsen metabolic outcomes. Conclusion: Artificial sweeteners are not metabolically inert and may affect insulin resistance in women with PCOS. Further research is needed to evaluate individual AS compounds and their long-term metabolic effects in this population, in order to inform dietary recommendations and optimize treatment outcomes.

  • Open Access

    Systemic Effects of Phosphodiesterase Type 5 Inhibitors Beyond Erectile Dysfunction: A Narrative Review

    by Wiktor Daniszewski, Wiktoria Knobelsdorf, Gabriela Furtak, Maria Łagódka, Michał Pogoda, Katarzyna Zając, Dominika Pietrzyk, Bartosz Oder, Maciej Ćmil, Wojciech Karchut

    Phosphodiesterase type 5 inhibitors (PDE5Is) are widely prescribed for erectile dysfunction; however, growing evidence indicates that their pharmacological effects extend beyond urological indications and involve multiple organ systems. This narrative review aims to synthesize and critically evaluate current evidence on the systemic effects of PDE5 inhibitors across cardiovascular, renal, neurological, and urological domains, as well as emerging therapeutic indications. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science for studies published up to May 2024, including preclinical studies, clinical trials, observational studies, systematic reviews, and meta-analyses. The reviewed evidence demonstrates that PDE5 inhibitors are associated with reduced cardiovascular morbidity and mortality, improvements in cardiac and pulmonary hemodynamics, preservation of renal function in diabetic populations, potential neuroprotective effects against cognitive decline and ischemic stroke, and symptomatic improvement in benign prostatic hyperplasia and lower urinary tract symptoms. Additional benefits have been reported in conditions characterized by vascular dysfunction, such as angina pectoris and Raynaud’s phenomenon. Overall, PDE5 inhibitors represent a pharmacologically versatile drug class with clinically relevant systemic effects beyond erectile dysfunction, supporting their potential role as adjunctive therapies in broader disease management, although further well-designed randomized controlled trials are needed to inform clinical guidelines.


  • Open Access

    THE IMPACT OF PHYSICAL ACTIVITY ON FEMALE FERTILITY- A REVIEW OF CURRENT LITERATURE

    by Katarzyna Zając, Bartosz Oder, Dominika Pietrzyk, Gabriela Furtak, Maria Łagódka, Michał Pogoda, Wiktor Daniszewski, Wiktoria Knobelsdorf, Wojciech Karchut, Maciej Ćmil

    Background. Physical activity is a key lifestyle factor influencing fertility. As more women delay pregnancy, it's important they understand which modifiable factors can impact their reproductive health. Aim. The aim of this article is to give women more accurate information. Present the data that is currently available to demonstrate how often, how intense, and which exercises are ideal for their reproductive system health when they participate in a sport that will help them keep or improve their fertility. Material and methods. A comprehensive literature search was conducted using PubMed, GoogleScholar, and WebScience databases, focusing on the following keywords: female fertility, physical activity, reproduction health, lifestyle factors and exercise. The search covered publications from 2002 to 2025. Results. Light to moderate physical activity (6 METs) improves ovulation and conception rates in overweight or obese women. However, prolonged intense exercise combined with a low-calorie diet can disrupt the hypothalamic-pituitary-gonadal axis, leading to irregular periods, anovulation, or secondary amenorrhea. Conclusions. One significant and modifiable component in the control and improvement of female fertility should be physical activity. However, light to moderate exercise is good for you and should be promoted, especially for women who have metabolic disorders or lead sedentary lives. The vigorous exercise may have a detrimental effect on reproductive health, apart from women who are overweight or obese.

  • Open Access

    THE ROLE OF PHYSICAL ACTIVITY IN THE TREATMENT OF HASHIMOTO’S THYROIDITIS – A LITERATURE REVIEW

    by Wiktoria Knobelsdorf, Wiktor Daniszewski, Gabriela Furtak, Maria Łagódka, Michał Pogoda, Katarzyna Zając, Dominika Pietrzyk, Bartosz Oder, Maciej Ćmil, Wojciech Karchut

    Introduction: The root cause of Hashimoto thyroiditis (HT), a chronic inflammation of the thyroid gland, is still not fully understood. HT has a multipronged influence on the general health condition, especially because the thyroid regulates the overall metabolism of an organism. Disruption of such a balance may result in weight gain and weakening of the muscles, and eventually resignation from any kind of physical activity. Objective: This work aims to review the current knowledge regarding the extent to which physical activity may play a role in the treatment of HT. Methods: Literature review of PubMed and Google Scholar. Conclusions: Although pharmacological treatment with levothyroxine remains the foundation of Hashimoto’s thyroiditis (HT) management, current evidence suggests that physical activity (PA) may play a supportive role in improving both thyroid function and overall quality of life. Regular and appropriately structured exercise appears to have beneficial effects on hormone levels, immune function, and common symptoms such as fatigue, weight gain, and reduced physical capacity. Findings indicate that not all forms of physical activity are equally effective. Voluntary, planned, and restorative exercise (RE) is associated with more favourable outcomes compared to occupational physical activity (OPA), which may exert additional stress on the body and worsen certain thyroid-related parameters. Future studies should focus on identifying the most effective exercise modalities and intensities, as well as their long-term impact on autoimmune activity and disease progression.

  • Open Access

    RHODIOLA ROSEA AS A NATURAL ADAPTOGEN: A REVIEW OF ITS EFFECTS ON STRESS REDUCTION, MOOD ENHANCEMENT, AND COGNITIVE FUNCTION

    by Maciej Ćmil, Wojciech Karchut, Gabriela Furtak, Wiktor Daniszewski, Wiktoria Knobelsdorf, Michał Pogoda, Bartosz Oder, Dominika Pietrzyk, Maria Łagódka, Katarzyna Zając

    Introduction: Rhodiola rosea is a widely used adaptogenic herb known for its potential to enhance the body’s resistance to physical and psychological stress. Traditionally employed in various medical systems, it has recently gained scientific attention for its beneficial effects on mood regulation, stress reduction, and cognitive performance. The complex phytochemical composition of Rhodiola rosea underpins these effects, yet the precise mechanisms and clinical efficacy remain to be fully elucidated. This review aims to comprehensively summarize current knowledge regarding the phytochemistry, mechanisms of action, preclinical and clinical evidence of Rhodiola rosea’s adaptogenic properties, focusing on its impact on stress reduction, mood enhancement, and cognitive function. Mechanisms of action involving modulation of the hypothalamic-pituitary-adrenal (HPA) axis, neurotransmitter systems, and antioxidant pathways are discussed. Despite promising results, further high-quality, large-scale randomized controlled trials are needed to establish standardized protocols for clinical use. Material and methods: A systematic literature analysis was conducted, including in vitro, animal, and human studies investigating Rhodiola rosea extracts. Emphasis was placed on studies examining biochemical pathways, neurobehavioral outcomes, and clinical trials assessing stress-related parameters, mood states, and cognitive metrics. Results: Rhodiola rosea exhibits modulatory effects on monoaminergic neurotransmission, enhances antioxidant defenses by upregulating enzymes such as superoxide dismutase and catalase, and improves mitochondrial function, leading to increased cellular energy production. Clinical studies demonstrate significant reductions in perceived stress and fatigue, improvements in mood disorders including mild to moderate depression, and enhanced psychomotor performance and cognitive processing speed. However, variability in extract standardization and study design influences the consistency of findings. Conclusions: Rhodiola rosea represents a promising natural adaptogen with multifaceted actions supporting stress resilience, mood stabilization, and cognitive enhancement. Standardized extracts with defined phytochemical profiles are essential to ensure reproducible therapeutic effects. Further rigorous clinical investigations are warranted to clarify optimal dosing regimens and long-term safety.